Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molsidomine for endothelial dysfunction after elective PCI in stable angina
2011-000190-31Phase 4Completed
- Sponsor
- Therabel
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in stable angina and coronary arteriosclerosis comparing Molsidomine plus standard care with Placebo plus standard care (2 arms). Primary endpoint: Change versus baseline in Endoscore at Month 12. Started Apr 2011; status: completed.
02
Drugs
molsidomine
03
Conditions
stable anginacoronary arteriosclerosis
Beyond the preview
Go deeper on 2011-000190-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000190-31.